Table 2. Summary of the immunohistochemistry results of selected CRC cases.
| molecular class | control | anti Gag-H clones | |||
|---|---|---|---|---|---|
| 14H11G1 | 1B3H7 | ||||
| Cytospins | |||||
| HROC113 | MSI | - | + | - | |
| HROC69 | MSS | - | weak | - | |
| HROBMC01 | MSI | - | ++ | ++ | |
| HROC32 | MSS | - | + | - | |
| HROC126 | MSS | - | + | - | |
| HROC147Met | MSS | - | + | + | |
| HROC87 T0 M2 | MSI | - | + | n.d. | |
| HHC6548 | MSI | - | n.d. | weak | |
| HROC18 | MSS | - | n.d. | + | |
| HROC40 | MSS | - | n.d. | + | |
| HROC24 | MSI | - | n.d. | + | |
| HROC147 | MSS | - | n.d. | + | |
| FFPE tissue pairs | |||||
| #1 T | MSS | - | + | n.d. | |
| #1 N | - | + | n.d. | ||
| #2 T | MSI | - | + | n.d. | |
| #2 N | - | weak | n.d. | ||
| #3 T | MSS | - | - | n.d. | |
| #3 N | - | weak | n.d. | ||
| #4 T | MSI | - | + | n.d. | |
| #4 N | - | weak | n.d. | ||
| #5 T | MSI | - | + | n.d. | |
| #5 N | - | + | n.d. | ||
| #6 T | MSS | - | + | n.d. | |
| #6 N | - | + | n.d. | ||
| #7 T | MSS | - | weak | n.d. | |
| #7 N | - | + | n.d. | ||
| #8 T | MSI | - | + | n.d. | |
| #8 N | - | + | n.d. | ||
| #9 T | MSI | - | + | n.d. | |
| #9 N | - | + | n.d. | ||
| #10 T | MSS | - | + | n.d. | |
| #10 N | - | + | n.d. | ||
| #11 T | MSI | - | + | n.d. | |
| #11 N | - | + | n.d. | ||
| #12 T | MSS | - | + | n.d. | |
| #12 N | - | + | n.d. | ||
| #13 T | MSS | - | + | n.d. | |
| #13 N | - | + | n.d. | ||
Control: antibodies 2G2B3 and 3D8C6E7; MSI, microsatellite instable; MSS, microsatellite stable; (+), moderate expression; (++), strong expression; (-), no expression; T, tumor; N, normal tissue; n.d., not done